MEDIVATOR CER-2 OPTIMA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2015-10-24 for MEDIVATOR CER-2 OPTIMA manufactured by Medivators.

Event Text Entries

[29174797] It was reported that positive cultures of mycobacterium were found in patients that had bronchoscopy procedures with endoscopes that were disinfected in a medivators cer-2 optima automated endoscope reprocessor. The facility mentioned that they tested patient cultures by flushing the cultures with sterile water at the end of the procedure and then tested that sample which tested positive. No actual patient biopsy pieces were tested for the bacteria. It was also reported that incoming unfiltered facility water tested positive for mycobacterium as well as the aer's basin drain, post filtration water, and water coming from hookups. It was predicted this bacteria was in the water not the patient. Medivators clinical specialist and medivators technical specialist has been in contact with this facility. Recommendations were made to the facility that the 1. 0 and 0. 2 micron filters be changed and replaced with medivators brand filters, and a waterline disinfection be performed. It was also recommended that additional cultures be obtained from the water exiting the hookup connectors immediately after wld. The facility has yet to share or contact medivators with the results of this evaluation, therefore conclusion not yet available. The cer-2 optima was evaluated and was operating according to specification. Medivators rapicide gluaraldehyde hld have been tested to successfully kill mycobacterium. There are no reports of patient related infections from this organism. This complaint will continue to be monitored and maintained within medivators complaint system.
Patient Sequence No: 1, Text Type: N, H10


[29174798] It was reported that positive cultures of mycobacterium were found in patients that had bronchoscopy procedures with endoscopes that were disinfected in a medivators cer automated endoscope reprocessor.
Patient Sequence No: 1, Text Type: D, B5


[47254556] It was reported that positive cultures of mycobacterium were found in patients that had bronchoscopy procedures with endoscopes that were disinfected in a medivators cer-2 optima automated endoscope reprocessor. The facility mentioned that they tested patient cultures by flushing the cultures with sterile water at the end of the procedure and then tested that sample which tested positive. No actual patient biopsy pieces were tested for the bacteria. It was also reported that incoming unfiltered facility water tested positive for mycobacterium as well as the aer's basin drain, post filtration water, and water coming from hookups. It was predicted this bacteria was in the water not the patient. Medivators clinical specialist and medivators technical specialist has been in contact with this facility. Recommendations were made to the facility that the 1. 0 and 0. 2 micron filters be changed and replaced with medivators brand filters, and a waterline disinfection be performed. It was also recommended that additional cultures be obtained from the water exiting the hookup connectors immediately after wld. The facility has yet to share or contact medivators with the results of this evaluation, therefore conclusion not yet available. The cer-2 optima was evaluated and was operating according to specification. Medivators rapicide gluaraldehyde hld have been tested to successfully kill mycobacterium. There are no reports of patient related infections from this organism. This complaint will continue to be monitored and maintained within medivators complaint system. On may 16th, 2016 - medivators field staff received notice that this facility continues to have issues with their scopes testing positive for mycobacterium cultures. It has been determined that this facility is not performing water line disinfection correctly. During investigation, it was discovered that they were not using the appropriate contact time for sanitizing at ambient temperature in accordance with the rapicide glutaraldehyde hld instructions for use. Medivators clinical staff and microbiology director has been in close contact with this facility to examine their processes. Medivators has requested samples from the facility so an internal investigation can be conducted by medivators micro team. To date, no samples have been returned. No reported patients affected.
Patient Sequence No: 1, Text Type: N, H10


[47254557] It was reported that positive cultures of mycobacterium were found in patients that had bronchoscopy procedures with endoscopes that were disinfected in a medivators cer automated endoscope reprocessor.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2150060-2015-00033
MDR Report Key5173650
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2015-10-24
Date of Report2015-10-22
Date of Event2015-09-23
Date Mfgr Received2015-09-23
Device Manufacturer Date2014-06-30
Date Added to Maude2015-10-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMEGAN DICKEY
Manufacturer Street14605 28TH AVE N
Manufacturer CityMINNEAPOLIS MN 55447
Manufacturer CountryUS
Manufacturer Postal55447
Manufacturer Phone7635533327
Manufacturer G1MEDIVATORS
Manufacturer Street14605 28TH AVE N
Manufacturer CityMINNEAPOLIS MN 55447
Manufacturer CountryUS
Manufacturer Postal Code55447
Single Use3
Remedial ActionPM
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMEDIVATOR CER-2 OPTIMA
Generic NameAUTOMATED ENDOSCOPE CLEANER WASHER
Product CodeNVE
Date Received2015-10-24
Model NumberCER-2 OPTIMA
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMEDIVATORS
Manufacturer Address14605 28TH AVE N MINNEAPOLIS MN 55447 US 55447


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2015-10-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.